Science and TechnologyScience and Technology
Tue, March 11, 2025
[ Today @ 03:21 AM ] - MoneyWeek
What is the S&P 500?
Mon, March 10, 2025

$30 Million Grant Supports AI-Powered Antibody Therapy Development


Published on 2025-03-10 23:22:25 - AZoLifeSciences
  Print publication without navigation

  • An ambitious project led by Vanderbilt University Medical Center investigators aims to use artificial intelligence technologies to generate antibody therapies against any antigen target of interest.

The article from MSN discusses a significant $30 million grant awarded to the University of California, San Francisco (UCSF) to advance the development of AI-powered antibody therapies. This funding, provided by the National Institute of Allergy and Infectious Diseases (NIAID), aims to accelerate the discovery and optimization of antibodies for treating infectious diseases. The project leverages AI and machine learning to analyze vast datasets, predicting how antibodies will interact with pathogens, thereby speeding up the process from discovery to clinical trials. This initiative not only focuses on enhancing the speed of antibody development but also on improving their effectiveness and safety, potentially transforming how we respond to future pandemics and other infectious threats.

Read the Full AZoLifeSciences Article at:
[ https://www.msn.com/en-gb/science/biology/30-million-grant-supports-ai-powered-antibody-therapy-development/ar-AA1AEFSc ]